Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer - Schmid, Peter; Adams, Sylvia; Rugo, Hope S.; Schneeweiss, Andreas; Barrios, Carlos H.; Iwata, Hiroji; Diéras, Véronique; Hegg, Roberto; Im, Seock-Ah; Wright, Gail Shaw; Henschel, Volkmar; Molinero, Luciana; et al. (The New England journal of medicine, 2018)
This article was published on October 20, 2018, and updated on November 15, 2018, at NEJM.org